Intended for healthcare professionals
Search
Toggle navigation
Current issue
Archive
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Editorial board
For authors
Advertising
Contact us
News
Web Exclusives
Register
FREE
Sign in
×
Remember me
Not registered?
Forgot your password?
Dermatology in practice – 2024
Autumn 2024, Volume 30 Number 3
The daily impact of living with dermatological conditions
Revealing the real burden of living with chronic hand eczema
Dr Angelika Razzaque
Dermatology Digital and Technology Solutions for the Treatment of Skin Conditions
Dermatology Team of the Year
Dermatology Education Programmes for Healthcare Professionals
Psychological Impact of Skin Disease
Dermatology Digital and Technology Solutions for the Treatment of Skin Conditions
BSF-funded research leads to breakthrough: oral contraceptive use linked to hair loss
A full programme of PCDS meetings
Dr Angelika Razzaque
Life in the fast lane
Barry Monk
Summer 2024, Volume 30 Number 2
The mental health impact of skin disorders
More common mistakes in dermatology
Ian H Coulson
Vitiligo – the impact on mental health
My dermatology mantra
Dr Lorna Patterson
Can weight loss improve skin disease for people living with psoriasis?
Dr Sarah Morrow
Glimmering of the gizzard and other hazards
Barry Monk
Spring 2024, Volume 30 Number 1
Comment - A helpful overview of some common mistakes
Common mistakes in dermatology
Ian H Coulson
Eczema: is allergy a contributor?
Nisa Aslam
PCDS celebrates its 30th anniversary
Dr Ben Kay
Self-destruct protein has potential to treat advanced skin cancer
Professor Dot Bennett, Dr Julia Soo
The Potemkin doctors
Barry Monk
Latest News
J&J presents positive phase 3b results for Tremfya in plaque psoriasis
Bristol Myers Squibb shares positive phase 3b/4 results for Sotyktu in scalp psoriasis
Eli Lilly/Almirall announce long-term results for IL-13 inhibitor Ebglyss in atopic dermatitis
LEO Pharma’s Anzupgo cream granted EC approval in chronic hand eczema
UCB announces two-year data for Bimzelx in hidradenitis suppurativa
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy